Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma
Jacalyn Rosenblatt(Beth Israel Deaconess Medical Center), David Avigan(Beth Israel Deaconess Medical Center)
Cited by 226
Related Papers
<scp>MUC</scp>1‐C drives myeloid leukaemogenesis and resistance to treatment by a survivin‐mediated mechanism
|Journal of Cellular and Molecular Medicine|2018|15